These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 9697710)
1. Parvovirus B19-induced anemia as the presenting manifestation of X-linked hyper-IgM syndrome. Seyama K; Kobayashi R; Hasle H; Apter AJ; Rutledge JC; Rosen D; Ochs HD J Infect Dis; 1998 Aug; 178(2):318-24. PubMed ID: 9697710 [TBL] [Abstract][Full Text] [Related]
2. Critical function of the CD40 pathway in parvovirus B19 infection revealed by a hypomorphic CD40 ligand mutation. Blaeser F; Kelly M; Siegrist K; Storch GA; Buller RS; Whitlock J; Truong N; Chatila TA Clin Immunol; 2005 Dec; 117(3):231-7. PubMed ID: 16169277 [TBL] [Abstract][Full Text] [Related]
3. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Seyama K; Nonoyama S; Gangsaas I; Hollenbaugh D; Pabst HF; Aruffo A; Ochs HD Blood; 1998 Oct; 92(7):2421-34. PubMed ID: 9746782 [TBL] [Abstract][Full Text] [Related]
4. CD40 ligand mutants responsible for X-linked hyper-IgM syndrome associate with wild type CD40 ligand. Seyama K; Osborne WR; Ochs HD J Biol Chem; 1999 Apr; 274(16):11310-20. PubMed ID: 10196221 [TBL] [Abstract][Full Text] [Related]
5. CD40 ligand expression deficiency in a female carrier of the X-linked hyper-IgM syndrome as a result of X chromosome lyonization. de Saint Basile G; Tabone MD; Durandy A; Phan F; Fischer A; Le Deist F Eur J Immunol; 1999 Jan; 29(1):367-73. PubMed ID: 9933119 [TBL] [Abstract][Full Text] [Related]
6. Mutations of the CD40 ligand gene in 13 Japanese patients with X-linked hyper-IgM syndrome. Nonoyama S; Shimadzu M; Toru H; Seyama K; Nunoi H; Neubauer M; Yata J; Och HD Hum Genet; 1997 May; 99(5):624-7. PubMed ID: 9150729 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus. van Elsacker-Neile AM; Kroon FP; van der Ende ME; Salimans MM; Spaan WJ; Kroes AC Clin Infect Dis; 1996 Dec; 23(6):1255-60. PubMed ID: 8953068 [TBL] [Abstract][Full Text] [Related]
9. Acute human parvovirus B-19 infection in hospitalized children: A serologic and molecular survey. Miron D; Luder A; Horovitz Y; Izkovitz A; Shizgreen I; Ben David E; Ohnona FS; Schlesinger Y Pediatr Infect Dis J; 2006 Oct; 25(10):898-901. PubMed ID: 17006284 [TBL] [Abstract][Full Text] [Related]
10. [Persistent parvovirus B19 infection in a patient with AIDS]. García-Tapia AM; Fernández C; Bascuñana A Enferm Infecc Microbiol Clin; 1993 Feb; 11(2):107-8. PubMed ID: 8386943 [No Abstract] [Full Text] [Related]
11. Human parvovirus B19 in patients with aplastic anemia. Mishra B; Malhotra P; Ratho RK; Singh MP; Varma S; Varma N Am J Hematol; 2005 Jun; 79(2):166-7. PubMed ID: 15929106 [TBL] [Abstract][Full Text] [Related]
12. Enteroviral meningoencephalitis as a complication of X-linked hyper IgM syndrome. Cunningham CK; Bonville CA; Ochs HD; Seyama K; John PA; Rotbart HA; Weiner LB J Pediatr; 1999 May; 134(5):584-8. PubMed ID: 10228294 [TBL] [Abstract][Full Text] [Related]
13. Preemptive intravenous immunoglobulin allows safe and timely administration of antineoplastic therapies in patients with multiple myeloma and parvovirus B19 disease. Katragadda L; Shahid Z; Restrepo A; Muzaffar J; Alapat D; Anaissie E Transpl Infect Dis; 2013 Aug; 15(4):354-60. PubMed ID: 23578205 [TBL] [Abstract][Full Text] [Related]
14. A novel splice-site mutation in the CD40L gene in a patient with X-linked hyper-IgM syndrome. Dezsö D; Orth U; Heilbronner H; Gal A Hum Mutat; 1996; 7(2):181-2. PubMed ID: 8829642 [No Abstract] [Full Text] [Related]
15. [From gene to disease; CD40 ligand deficiency as the cause of X-linked hyper-IgM-syndrome]. Groeneweg M; Lankester AC; Bredius RG Ned Tijdschr Geneeskd; 2003 May; 147(21):1009-11. PubMed ID: 12811971 [TBL] [Abstract][Full Text] [Related]
16. Persistence of parvovirus B19 IgM antibodies and DNA in pure red cell aplasia resulting in myelodysplasia--a case report. Kishore J; Mukhopadhyay C Indian J Pathol Microbiol; 2004 Jan; 47(1):78-81. PubMed ID: 15471143 [TBL] [Abstract][Full Text] [Related]
17. [Secondary autoimmune hemolytic anemia as a result of B19 parvovirus persistence in immunodeficient patients]. Iaguzhinskaia OE; Fevraleva IS; Elizhbaeva MA; Levina AA; Semenova GM; Bugar' NIu; Tsybul'skaia LM; Varlamova EIu; Shitareva IV; Tsyba NI; Kravchenko SK Ter Arkh; 2011; 83(12):62-8. PubMed ID: 22416448 [TBL] [Abstract][Full Text] [Related]
18. Molecular pathology of the X-linked hyper-immunoglobulin M syndrome: detection of wild-type transcripts in a patient with a complex splicing defect of the CD40 ligand. Ameratunga R; McKee J; French J; Prestidge R; Fanslow W; Marbrook J Clin Diagn Lab Immunol; 1996 Nov; 3(6):722-6. PubMed ID: 8914765 [TBL] [Abstract][Full Text] [Related]
19. Characterization of nine novel mutations in the CD40 ligand gene in patients with X-linked hyper IgM syndrome of various ancestry. Macchi P; Villa A; Strina D; Sacco MG; Morali F; Brugnoni D; Giliani S; Mantuano E; Fasth A; Andersson B Am J Hum Genet; 1995 Apr; 56(4):898-906. PubMed ID: 7717401 [TBL] [Abstract][Full Text] [Related]
20. Mutational screening of the CD40 ligand (CD40L) gene in patients with X linked hyper-IgM syndrome (XHIM) and determination of carrier status in female relatives. Prasad ML; Velickovic M; Weston SA; Benson EM J Clin Pathol; 2005 Jan; 58(1):90-2. PubMed ID: 15623492 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]